Its mutation has been described in more than half of human tumors and it codes for a protein with abnormal stability and long half-life that allows its detection via immunohistochemistry using specific antibodies.10 p53 expression and mutation has been correlated with advanced disease, loss of tumor differentiation and the transition from androgen-dependent to androgen-independent growth.11-13. This evidence concerns the gene TP53 and neoplasm.